A. Thomas McCourt's Insider Trades & SAST Disclosures
A. Thomas McCourt's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 139,064 Class A Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Feb. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Thomas McCourt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 139,064 | 1,160,634 (0%) | 0% | 1.8 | 244,753 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 147,354 | 1,299,698 (0%) | 0% | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 20 May 2024 | 67,618 | 1,150,330 (0%) | 0% | 6.4 | 436,136 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 120,298 | 0 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 120,298 | 1,217,948 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 264,876 | 1,097,650 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 132,438 | 132,438 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharmaceuticals I... | A. Thomas McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 12 Feb 2024 | 177,164 | 832,774 (0%) | 0% | 15.2 | 2,699,979 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | A. Thomas McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 249,617 | 1,009,938 (0%) | 0% | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.70 per share. | 30 May 2023 | 26,632 | 758,284 (0%) | 0% | 10.7 | 284,962 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 22 May 2023 | 36,000 | 784,916 (0%) | 0% | 10.1 | 364,320 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.62 per share. | 08 May 2023 | 21,148 | 820,916 (0%) | 0% | 10.6 | 224,592 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.67 per share. | 27 Mar 2023 | 46,129 | 842,064 (0%) | 0% | 10.7 | 492,196 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 240,595 | 888,193 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 120,297 | 120,297 | - | - | Performance-based Restricted Stock Units | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.22 per share. | 03 Mar 2023 | 33,756 | 647,598 (0%) | 0% | 11.2 | 378,742 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 26,639 | 685,942 (0%) | 0% | 11.3 | 301,287 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 25,595 | 716,990 (0%) | 0% | 11.4 | 292,039 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 4,588 | 681,354 (0%) | 0% | 11.3 | 51,890 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 4,409 | 712,581 (0%) | 0% | 11.4 | 50,307 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 30,145 | 742,585 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 05 Jan 2023 | 110,962 | 712,440 (0%) | 0% | 12.1 | 1,339,311 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 110,962 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.65 per share. | 05 Jan 2023 | 110,962 | 823,402 (0%) | 0% | 11.6 | 1,292,707 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 03 Oct 2022 | 18,899 | 712,440 (0%) | 0% | 10.4 | 196,739 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.65 per share. | 01 Sep 2022 | 26,446 | 731,339 (0%) | 0% | 10.7 | 281,650 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.35 per share. | 01 Aug 2022 | 23,229 | 757,785 (0%) | 0% | 11.3 | 263,649 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 30 Jun 2022 | 19,959 | 778,922 (0%) | 0% | 11.6 | 231,125 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 21,873 | 810,729 (0%) | 0% | 11.5 | 251,540 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 11,848 | 798,881 (0%) | 0% | 11.5 | 136,252 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 2,587 | 832,602 (0%) | 0% | 11.5 | 29,751 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 248,869 | 835,189 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 19,970 | 602,806 (0%) | 0% | 10.8 | 215,077 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 16,486 | 586,320 (0%) | 0% | 10.8 | 177,554 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 10,026 | 622,776 (0%) | 0% | 10.8 | 107,980 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 1,942 | 632,802 (0%) | 0% | 10.8 | 20,915 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 60,290 | 634,744 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 22 Dec 2021 | 46,327 | 574,454 (0%) | 0% | 11.4 | 528,591 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 23 Nov 2021 | 52,644 | 618,545 (0%) | 0% | 11.6 | 609,618 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 104,690 | 671,189 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President and Interim CEO | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 24 May 2021 | 1,716 | 566,499 (0%) | 0% | 12.3 | 21,021 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President and Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 96,638 | 568,215 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 10,265 | 471,577 (0%) | 0% | 9.1 | 93,514 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 2,582 | 483,680 (0%) | 0% | 9.1 | 23,522 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 1,838 | 481,842 (0%) | 0% | 9.1 | 16,744 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 145,631 | 486,262 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.89 per share. | 14 Dec 2020 | 99,988 | 421,720 (0%) | 0% | 9.9 | 988,881 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 99,988 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.20 per share. | 14 Dec 2020 | 81,089 | 340,631 (0%) | 0% | 12.2 | 989,286 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Thomas A. McCourt | President | Sale of securities on an exchange or to another person at price $ 10.35 per share. | 11 May 2020 | 1,697 | 319,847 (0%) | 0% | 10.4 | 17,564 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges